This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Apple says Masimo's US trade secret case is weak, confidentiality agreement with ex-scientist was invalid

( October 29, 2024, 10:10 GMT | Official Statement) -- MLex Summary: Allegations by Masimo that a former scientist took with him to Apple trade secrets relating to blood-oxygen sensor technology are plagued with problems, Apple says in a pre-trial brief.  Not only was the employee confidentiality agreement between Masimo and Marcelo Lamego "invalid and anticompetitive," according to Apple, "but the Apple Watch, including its health sensing features, was well into development when Dr. Lamego worked at Apple for a mere six months in 2014." Moreover, Apple adds, "there is nothing wrong with an employee changing jobs."See attached document....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections